Publications by authors named "Howard-C Thomas"

Claim this Profile
P
Polymorphisms in Natural Killer Cell Receptor Protein 2D (NKG2D) as a Risk Factor for Cholangiocarcinoma.
Christopher A Wadsworth, Peter H Dixon, Simon Taylor-Robinson, Jin U Kim, Abigail A Zabron, Howard C Thomas

J Clin Exp Hepatol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic variation in GABRβ1 and the risk for developing alcohol dependence.
William A McCabe, Michael J Way, Kush Ruparelia, Susanne Knapp, M Adam Ali, Howard C Thomas

Psychiatr Genet· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: evidence for genotype-specific regulation of lipoprotein metabolism.
Simon H Bridge, David A Sheridan, Daniel J Felmlee, Mary M E Crossey, Fiona I Fenwick, Howard C Thomas

J Hepatol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in the Gabrb1 gene promote alcohol consumption through increased tonic inhibition.
Quentin M Anstee, Susanne Knapp, Edward P Maguire, Alastair M Hosie, Philip Thomas, Howard C Thomas

Nat Commun· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial.
David A Sheridan, Simon H Bridge, Mary M E Crossey, Daniel J Felmlee, Fiona I Fenwick, Howard C Thomas

Liver Int· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of neural activation following treatment of hepatic encephalopathy.
Mark J W McPhail, Robert Leech, Vijay P B Grover, Julie A Fitzpatrick, Novraj S Dhanjal, Howard C Thomas

Neurology· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update.
Shahid A Khan, Brian R Davidson, Robert D Goldin, Nigel Heaton, John Karani, Howard C Thomas

Gut· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivity.
David A Sheridan, Simon H Bridge, Daniel J Felmlee, Mary M E Crossey, Howard C Thomas

J Hepatol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid profiling of pre-treatment liver biopsy tissue predicts sustained virological response in patients with chronic hepatitis C.
Jeremy F L Cobbold, I Jane Cox, Ashley S Brown, Horace R T Williams, Robert D Goldin, Howard C Thomas

Hepatol Res· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy and reliability of microbubble ultrasound measurements for the non-invasive assessment of hepatic fibrosis in chronic hepatitis C.
Jeremy F L Cobbold, Dhupal Patel, Julie A Fitzpatrick, Nayna Patel, Mary M E Crossey, Howard C Thomas

Hepatol Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma: diagnostics and screening.
Madhvi Patel, Mohamed I F Shariff, Nimzing G Ladep, Andrew V Thillainayagam, Howard C Thomas

J Eval Clin Pract· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
Shahid A Khan, Shireen Emadossadaty, Nimzing G Ladep, Howard C Thomas, Paul Elliott

J Hepatol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic factors in the pathogenesis of cholangiocarcinoma.
Christopher A Wadsworth, Peter H Dixon, Jason H Wong, Michael H Chapman, Siobhan C McKay, Howard C Thomas

Dig Dis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.
John C Chambers, Weihua Zhang, Joban Sehmi, Xinzhong Li, Mark N Wass, Howard C Thomas

Nat Genet· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-excitation fluorescence spectroscopy for analysis of non-alcoholic fatty liver disease.
Vincent R Sauvage, Adam P Levene, Hoa T Nguyen, Tobias C Wood, Hiromi Kudo, Howard C Thomas

Lasers Surg Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma.
Mohamed S Hashim Abdalla, Simon D Taylor-Robinson, Amar W Sharif, Horace R T Williams, Mary M E Crossey, Howard C Thomas

HPB (Oxford)· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance and low-density apolipoprotein B-associated lipoviral particles in hepatitis C virus genotype 1 infection.
Simon H Bridge, David A Sheridan, Daniel J Felmlee, Søren U Nielsen, Howard C Thomas

Gut· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of single-voxel clinical in vivo hepatic 31P MR spectra acquired at 1.5 and 3.0 Tesla in health and diseased states.
Marzena Wylezinska, Jeremy F L Cobbold, Julie Fitzpatrick, Mark J W McPhail, Mary M E Crossey, Howard C Thomas

NMR Biomed· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remodelling of extracellular matrix is a requirement for the hepatic progenitor cell response.
Yiannis N Kallis, Andrew J Robson, Jonathan A Fallowfield, Howard C Thomas, Malcolm R Alison

Gut· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation study.
Mohamed I F Shariff, Asmaa I Gomaa, I Jane Cox, Madhvi Patel, Horace R T Williams, Howard C Thomas

J Proteome Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy for chronic viral hepatitis: current indications, optimal therapies and delivery of care.
Matthew L Cowan, Howard C Thomas, Graham R Foster

Clin Med (Lond)· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in imaging hepatic fibrosis and steatosis.
Kayur D Patel, Kushala W M Abeysekera, Matko Marlais, Mark J W McPhail, Howard C Thomas, E Louise Thomas

Expert Rev Gastroenterol Hepatol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis.
Quentin M Anstee, Danilo Concas, Hiromi Kudo, Adam Levene, John Pollard, Howard C Thomas

J Hepatol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic profiling of bile in cholangiocarcinoma using in vitro magnetic resonance spectroscopy.
Amar W Sharif, Horace R T Williams, Temi Lampejo, Shahid A Khan, Devinder S Bansi, Howard C Thomas

HPB (Oxford)· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating mildly abnormal serum aminotransferase values.
Jeremy F L Cobbold, Quentin M Anstee, Howard C Thomas

BMJ· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis